{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:29:16Z","timestamp":1790857756030,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.healun.2005.01.013","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T12:14:06Z","timestamp":1110975246000},"page":"S185-S190","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["From Clinical Trials to Clinical Practice: An Overview of Certican\u00ae (Everolimus) in Heart Transplantation"],"prefix":"10.1016","volume":"24","author":[{"given":"Hannah","family":"Valantine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2005.01.013_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1053-2498(03)00186-4","article-title":"The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report\u20142003","volume":"22","author":"Taylor","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.01.013_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.TP.0000071200.37399.1D","article-title":"Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy","volume":"76","author":"Sharples","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1600-6143.2003.00316.x","article-title":"The role of viruses in cardiac allograft vasculopathy","volume":"4","author":"Valantine","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2005.01.013_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9149(99)00631-1","article-title":"Cyclosporine versus tacrolimus (FK506) for prevention of cardiac allograft vasculopathy","volume":"85","author":"Klauss","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2005.01.013_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib6","doi-asserted-by":"crossref","unstructured":"Kobashigawa J. Further analysis of the intravascular ultrasound (IVUS) data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients. Data presented at the 24th annual meeting of the International Society for Heart and Lung Transplantation, San Francisco, CA, April 2004.","DOI":"10.1016\/j.healun.2003.11.003"},{"key":"10.1016\/j.healun.2005.01.013_bib7","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1016\/S0041-1345(01)02369-7","article-title":"The role of Certican\u00ae (everolimus, RAD) in the many pathways of chronic rejection","volume":"33","author":"Nashan","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2005.01.013_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2005.01.013_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/ajrccm.163.2.2006093","article-title":"40-o-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats","volume":"163","author":"Nishimura","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2005.01.013_bib11","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1161\/01.CIR.0000033973.06059.04","article-title":"Oral everolimus inhibits in-stent neointimal growth","volume":"106","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2005.01.013_bib12","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0041-1345(98)00590-9","article-title":"Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model","volume":"30","author":"Cole","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2005.01.013_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0041-1345(98)01885-5","article-title":"SDZ RAD inhibits cold ischemia-induced vascular remodeling","volume":"31","author":"Schuurman","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2005.01.013_bib14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.TP.0000090393.75600.32","article-title":"Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid artery allografts in apolipoprotein E-deficient mice","volume":"76","author":"Matsumoto","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib15","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2005.01.013_bib16","doi-asserted-by":"crossref","unstructured":"Haverich A, Tuzcu EM, Vigan\u00f2 M, et al. Everolimus in de novo cardiac transplant recipients: 24-month follow-up (abstract). J Heart Lung Transplant 2003;22(Suppl 1S):S140.","DOI":"10.1016\/S1053-2498(02)00902-6"},{"issue":"suppl 3","key":"10.1016\/j.healun.2005.01.013_bib17","first-page":"247","article-title":"12-Month results of a multicenter study comparing efficacy and safety of everolimus to azathioprine in de novo cardiac transplant recipients (abstract)","volume":"2","author":"Valentine","year":"2002","journal-title":"Am J Transplant"},{"issue":"suppl A","key":"10.1016\/j.healun.2005.01.013_bib18","first-page":"90A","article-title":"Everolimus reduces cardiac allograft vasculopathy in de novo heart transplant recipients: 24 month follow-up (abstract)","volume":"19","author":"Hauck","year":"2003","journal-title":"Can J Cardiol"},{"issue":"suppl 5","key":"10.1016\/j.healun.2005.01.013_bib19","first-page":"550","article-title":"24-Month results of a multicenter study of everolimus for the prevention of allograft rejection and vasculopathy in de novo cardiac transplant recipients","volume":"3","author":"Mancini","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2005.01.013_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1053-2498(99)00128-X","article-title":"Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging","volume":"19","author":"Kapadia","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.01.013_bib21","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1161\/01.CIR.92.12.3445","article-title":"Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation","volume":"92","author":"Rickenbacher","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2005.01.013_bib22","doi-asserted-by":"crossref","unstructured":"Kobashigawa JA, Tobis JA, Starling RC, et al. Multicenter intravascular ultrasound (IVUS) validation study among heart transplant recipients: outcomes after 5 years. J Am Coll Cardiol 2005;45:1532\u20137.","DOI":"10.1016\/j.jacc.2005.02.035"},{"key":"10.1016\/j.healun.2005.01.013_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","article-title":"Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study","volume":"20","author":"Jiminez","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2005.01.013_bib24","unstructured":"Data on file, Novartis Pharma AG, Basel, Switzerland."},{"key":"10.1016\/j.healun.2005.01.013_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-200203270-00016","article-title":"Exposure\u2013response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range","volume":"73","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1600-6143.2004.00601.x","article-title":"Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure\u2013effect modeling","volume":"4","author":"Starling","year":"2004","journal-title":"Am J Transplantation"},{"key":"10.1016\/j.healun.2005.01.013_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.healun.2005.05.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000}}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249805000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249805000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T09:37:11Z","timestamp":1586165831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249805000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1053249805000720"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2005.01.013","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}